Creative BioMart to Present at
                        BIO-Europe Spring Creative BioMart to Present at IMMUNOLOGY2024™|May 3-7, 2024|Booth #512

Recombinant Zebrafish AP2M1A

Cat.No. : AP2M1A-8435Z
Product Overview : Recombinant Zebrafish AP2M1A full length or partial length protein was expressed.
  • Specification
  • Gene Information
  • Related Products
  • Download
Source : Mammalian Cells
Species : Zebrafish
Tag : His
Form : Liquid or lyophilized powder
Endotoxin : < 1.0 eu per μg of the protein as determined by the LAL method.
Purity : >80%
Notes : This item requires custom production and lead time is between 5-9 weeks. We can custom produce according to your specifications.
Storage : Store it at +4 oC for short term. For long term storage, store it at -20 oC~-80 oC.
Storage Buffer : PBS buffer
Gene Name : ap2m1a adaptor-related protein complex 2, mu 1 subunit, a [ Danio rerio (zebrafish) ]
Official Symbol : AP2M1A
Gene ID : 321051
mRNA Refseq : NM_001291355
Protein Refseq : NP_001278284
UniProt ID : Q6NWK2

For Research Use Only. Not intended for any clinical use. No products from Creative BioMart may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative BioMart.

Inquiry

  • Q&As
  • Reviews

Q&As (18)

Ask a question
What technologies are needed for the synthesis of AP2M1A ? 11/11/2022

The synthesis of AP2M1A can be achieved by protein engineering, gene recombination and fermentation technology.

What is the role of AP2M1A? 07/31/2022

The AP2M1A can be used as a biomarker for the diagnosis and treatment of malignant tumors such as breast cancer.

How to detect the expression of AP2M1A ? 05/20/2022

The expression of AP2M1A can be detected by immunohistochemistry, immunofluorescence and enzyme-linked immunosorbent assay.

What are the limitations of the clinical application of recombinant AP2M1A? 05/11/2022

At present, the clinical application of recombinant AP2M1A is limited by sample size, detection methods and experimental specifications.

How accurate is the diagnosis of AP2M1A ? 03/11/2022

The diagnostic accuracy of AP2M1A as a tumor marker depends on the specific detection method used and its clinical application.

Is the expression of recombinant AP2M1A related to the prognosis of cancer? 12/09/2021

Yes, expression of AP2M1A is closely related to cancer prognosis, and patients with high expression levels have a relatively poor prognosis.

Is there polymorphism in AP2M1A gene? 08/02/2021

Yes, there are polymorphisms in the AP2M1A gene, including single nucleotide polymorphisms and frameshift mutations.

What is the role of recombinant AP2M1A in tumor therapy? 05/30/2021

At present, AP2M1A can be used as a potential drug for targeted therapy, and has certain inhibitory effect on breast cancer, gastric cancer and other tumors.

Can recombinant AP2M1A be used as a single marker in the diagnosis of tumors? 02/22/2021

No, the recombinant AP2M1A protein needs to be used in conjunction with other tumor markers to improve the accuracy of cancer diagnosis.

What are the effects of changes in the expression of AP2M1A in cancer therapy? 08/05/2020

The change of expression of AP2M1A may be related to the therapeutic effect, but further studies are needed to confirm it.

Is recombinant AP2M1A widely used in clinical preventive screening? 07/29/2020

At present, the application of AP2M1A in clinical preventive screening is still in the exploration stage.

What are the advantages of recombinant AP2M1A compared with other tumor markers? 03/26/2020

Compared with other tumor markers, AP2M1A is expressed earlier in the tumor growth process, and its expression is closely related to the degree of tumor cell invasion and prognosis.

Can AP2M1A replace traditional chemotherapy and radiotherapy in the treatment of malignant tumors? 01/21/2020

At present, there is no sufficient evidence to support the ability of recombinant AP2M1A to replace conventional chemotherapy and radiotherapy.

What is AP2M1A ? 11/09/2019

The AP2M1A is an artificially manufactured protein constructed from the protein sequence encoded by the human AP2M1A gene.

The AP2M1A is helpful in the diagnosis of which malignant tumors? 06/18/2019

AP2M1A can be used in the diagnosis of breast cancer, lung cancer, stomach cancer, colon cancer, cervical cancer and other malignant tumors.

What is the role of AP2M1A expression in tumor metastasis? 04/08/2019

The expression of AP2M1A is closely related to the invasion and metastasis of malignant tumors, and may be used as a potential marker for the study of tumor metastasis.

How to regulate the expression of AP2M1A at the gene level? 03/31/2019

At present, molecular genetics and epigenetics can be used to regulate the expression of AP2M1A gene.

What is the prospect of clinical application of recombinant AP2M1A? 01/25/2019

As a tumor marker, AP2M1A has diagnostic and therapeutic potential. With the progress of related technology and research, its prospect in clinical application is worth looking forward to.

Customer Reviews (4)

Write a review
Reviews
01/02/2021

    It can simplify complex chemical reactions and improve high yield, and its scientific research value is self-evident.

    04/01/2020

      AP2M1A of this recombinant protein is very environmentally friendly.

      01/09/2020

        AP2M1A production process is strictly controlled and the product quality is guaranteed.

        07/20/2019

          The reproducibility of AP2M1A is simply unmatched, and the results are identical in every experiment or application, fully demonstrating its high stability and reliability.

          Ask a Question for All AP2M1A Products

          Required fields are marked with *

          My Review for All AP2M1A Products

          Required fields are marked with *

          0

          Inquiry Basket

          cartIcon
          logo

          FOLLOW US

          Terms and Conditions        Privacy Policy

          Copyright © 2024 Creative BioMart. All Rights Reserved.

          Contact Us

          • /

          Stay Updated on the Latest Bioscience Trends